LMNA and lipodystrophy: These effects of vupanorsen were independent of genetic confirmation of diagnosis of FPLD [9], as they were observed in patients classified as FPLD2 with mutations in the LMNA gene, as well as in patients with FLPD1 with no causative single genetic variants identified in known lipodystrophy genes.